Physician profile
Mallory Pate
NPI 1033816087
$977.22
in general payments reported to CMS, 2019-2025
16 companies · $14.87 in 2025
The $14.87 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $438 · 2024: $524 · 2025: $14.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $930 · Education: $46.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $930.31 |
| Education | $46.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $259.54 | 2023-2024 | |
| Novo Nordisk INC | $225.74 | 2023-2024 | Rybelsus, Wegovy, Ozempic |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $109.29 | 2023 | |
| Axsome Therapeutics, INC. | $60.37 | 2023-2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $53.18 | 2023-2024 | Rexulti |
| Exact Sciences Corporation | $47.31 | 2024 | Cologuard Collection Kit |
| Amgen INC. | $45.82 | 2024 | Otezla, Repatha |
| Azurity Pharmaceuticals, INC. | $29.60 | 2024 | Horizant |
| Regeneron Healthcare Solutions, INC. | $23.59 | 2024 | Evkeeza |
| Bayer Healthcare Pharmaceuticals INC. | $22.77 | 2023 | |
| Glaxosmithkline, LLC. | $19.39 | 2023 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $18.91 | 2024 | Farxiga |
| Pfizer INC. | $17.18 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.40 | 2024 | Trulance, Xifaxan |
| Lilly USA, LLC | $14.55 | 2023 | Mounjaro |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $13.58 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mallory Pate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.